JP2932101B2 - Plasma filtration method and apparatus therefor - Google Patents

Plasma filtration method and apparatus therefor

Info

Publication number
JP2932101B2
JP2932101B2 JP4506572A JP50657293A JP2932101B2 JP 2932101 B2 JP2932101 B2 JP 2932101B2 JP 4506572 A JP4506572 A JP 4506572A JP 50657293 A JP50657293 A JP 50657293A JP 2932101 B2 JP2932101 B2 JP 2932101B2
Authority
JP
Japan
Prior art keywords
plasma
secondary filter
filter
inner chamber
washing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP4506572A
Other languages
Japanese (ja)
Other versions
JPH06503362A (en
Inventor
明夫 川村
元樹 米川
栄治 坂下
弘 鴨川
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
OOTSUKA SEIYAKU KOJO KK
Original Assignee
OOTSUKA SEIYAKU KOJO KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by OOTSUKA SEIYAKU KOJO KK filed Critical OOTSUKA SEIYAKU KOJO KK
Priority claimed from PCT/EP1992/002131 external-priority patent/WO1993007234A1/en
Publication of JPH06503362A publication Critical patent/JPH06503362A/en
Application granted granted Critical
Publication of JP2932101B2 publication Critical patent/JP2932101B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C25/00Compounds containing at least one halogen atom bound to a six-membered aromatic ring
    • C07C25/24Halogenated aromatic hydrocarbons with unsaturated side chains
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • C07C255/49Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C255/50Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton to carbon atoms of non-condensed six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00Ethers; Compounds having groups, groups or groups
    • C07C43/02Ethers
    • C07C43/03Ethers having all ether-oxygen atoms bound to acyclic carbon atoms
    • C07C43/14Unsaturated ethers
    • C07C43/17Unsaturated ethers containing halogen
    • C07C43/172Unsaturated ethers containing halogen containing rings other than six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00Ethers; Compounds having groups, groups or groups
    • C07C43/02Ethers
    • C07C43/03Ethers having all ether-oxygen atoms bound to acyclic carbon atoms
    • C07C43/14Unsaturated ethers
    • C07C43/17Unsaturated ethers containing halogen
    • C07C43/174Unsaturated ethers containing halogen containing six-membered aromatic rings
    • C07C43/176Unsaturated ethers containing halogen containing six-membered aromatic rings having unsaturation outside the aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00Ethers; Compounds having groups, groups or groups
    • C07C43/02Ethers
    • C07C43/18Ethers having an ether-oxygen atom bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C07C43/192Ethers having an ether-oxygen atom bound to a carbon atom of a ring other than a six-membered aromatic ring containing halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00Ethers; Compounds having groups, groups or groups
    • C07C43/02Ethers
    • C07C43/20Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
    • C07C43/225Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring containing halogen
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/06Non-steroidal liquid crystal compounds
    • C09K19/08Non-steroidal liquid crystal compounds containing at least two non-condensed rings
    • C09K19/30Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing saturated or unsaturated non-aromatic rings, e.g. cyclohexane rings
    • C09K19/3001Cyclohexane rings
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/06Non-steroidal liquid crystal compounds
    • C09K19/34Non-steroidal liquid crystal compounds containing at least one heterocyclic ring
    • C09K19/3402Non-steroidal liquid crystal compounds containing at least one heterocyclic ring having oxygen as hetero atom
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/06Non-steroidal liquid crystal compounds
    • C09K19/34Non-steroidal liquid crystal compounds containing at least one heterocyclic ring
    • C09K19/3441Non-steroidal liquid crystal compounds containing at least one heterocyclic ring having nitrogen as hetero atom
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/06Non-steroidal liquid crystal compounds
    • C09K19/34Non-steroidal liquid crystal compounds containing at least one heterocyclic ring
    • C09K19/3441Non-steroidal liquid crystal compounds containing at least one heterocyclic ring having nitrogen as hetero atom
    • C09K19/345Non-steroidal liquid crystal compounds containing at least one heterocyclic ring having nitrogen as hetero atom the heterocyclic ring being a six-membered aromatic ring containing two nitrogen atoms
    • C09K19/3458Uncondensed pyrimidines
    • C09K19/3469Pyrimidine with a specific end-group other than alkyl, alkoxy or -C*-
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/42Mixtures of liquid crystal compounds covered by two or more of the preceding groups C09K19/06 - C09K19/40
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/12Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14The ring being saturated
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/06Non-steroidal liquid crystal compounds
    • C09K19/34Non-steroidal liquid crystal compounds containing at least one heterocyclic ring
    • C09K19/3402Non-steroidal liquid crystal compounds containing at least one heterocyclic ring having oxygen as hetero atom
    • C09K2019/3422Non-steroidal liquid crystal compounds containing at least one heterocyclic ring having oxygen as hetero atom the heterocyclic ring being a six-membered ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Liquid Crystal Substances (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • External Artificial Organs (AREA)

Description

【発明の詳細な説明】 技術分野 本発明血漿濾過法及びその装置、より詳しくは、血漿
濾過法における2次フィルタ部分の洗浄再生法及びその
装置の改良に関する。
Description: TECHNICAL FIELD The present invention relates to a plasma filtration method and an apparatus therefor, and more particularly, to a method for washing and regenerating a secondary filter portion in a plasma filtration method and an improvement of the apparatus.

背景技術 慢性関節リウマチや全身性エリテマト−デスなどのあ
る種の疾患では、患者の血液中にその病因となっている
高分子量物質が存在することが種々の研究により明らか
になってきた。そこで、上記高分子量物質を患者の血液
から除去することによって、疾患を治療し症状を軽減す
ることが試みられ、その手段の一つとして血漿濾過法が
採用されている。
BACKGROUND ART Various studies have revealed that high-molecular-weight substances causing the pathology of certain diseases such as rheumatoid arthritis and systemic lupus erythematosus are present in the blood of patients. Therefore, it has been attempted to treat the disease and reduce the symptoms by removing the high molecular weight substance from the blood of the patient, and a plasma filtration method has been adopted as one of the means.

血漿濾過法とは、患者から採取した血液をまず血球と
血漿に分離する1次フィルタ処理と、血漿から有害高分
子量物質を除去し浄化する2次フィルタ処理を含み、2
次フィルタよりの浄化血漿を、1次フィルタよりの血球
と再混合して血液供給源(患者)に戻すシステムであ
る。
The plasma filtration method includes a primary filter treatment for separating blood collected from a patient into blood cells and plasma first, and a secondary filter treatment for removing and purifying harmful high molecular weight substances from plasma.
This is a system in which purified plasma from the secondary filter is remixed with blood cells from the primary filter and returned to the blood supply source (patient).

上記血漿濾過法は、2次フィルタでの高分子量物質の
濾過のしくみにより2種に大別される。即ち、2次フィ
ルタの孔径によって除去する物質を選択する方法(二重
濾過血漿分離交換法)と、血漿を一端4℃程度まで冷却
し、血漿中の有害成分である高分子量物質を含むゲル
(いわゆるクライオゲル)を生成させてこれを比較的目
の粗い2次フィルタで篩い分ける方法(血漿冷却濾過
法)とがあり、後者は有害高分子量物質が確実に除去で
きる点で有利であるので、近年注目されつつある(例え
ば特公平1-34626号公報参照)。
The plasma filtration method is roughly classified into two types according to a mechanism of filtering a high molecular weight substance by a secondary filter. That is, a method of selecting a substance to be removed according to the pore size of a secondary filter (double filtration plasma separation / exchange method), and a method of cooling plasma once to about 4 ° C. and gel containing a high molecular weight substance which is a harmful component in plasma ( There is a method in which a so-called cryogel is produced and sieved with a relatively coarse secondary filter (plasma cooling filtration method). The latter is advantageous in that harmful high molecular weight substances can be reliably removed. It is receiving attention (for example, see Japanese Patent Publication No. 1-334626).

血漿冷却濾過法は、血漿の冷却手段があることと2次
フィルタの孔径が異なることの他は二重濾過血漿分離交
換方法のしくみとほとんど共通しており、その方法を図
4のもとづき説明すると、血液はその供給源から血液ポ
ンプ1の作動をして血液供給ライン2を通じ1次フィル
タ3に送られ、ここで血球と血漿とに分離され、分離血
球は、下記の浄化血漿と再混合するために、血球返送ラ
イン4側に送られる。
The plasma cooling filtration method is almost the same as the double filtration plasma separation / exchange method except that the plasma cooling means is provided and the pore size of the secondary filter is different. The method will be described with reference to FIG. The blood is sent from its source to the primary filter 3 through the blood supply line 2 by operating the blood pump 1, where it is separated into blood cells and plasma, and the separated blood cells are remixed with the purified plasma described below. Is sent to the blood cell return line 4 side.

一方血漿は血漿ポンプ5の作動をして血漿供給ライン
6から該ライン6上の冷却コイル部7をへて2次フィル
タ8内に送られ、ここで濾過される。血漿は上記コイル
部7で通常4℃〜25℃、好ましくは4℃付近まで冷却さ
れ、この冷却で生成した高分子量物質のクライオゲル
は、2次フィルタでの濾過処理により血漿中から除去さ
れる。2次フィルタよりの濾液即ち浄化血漿は浄化血漿
返送ライン9をへて返送されつつ先の1次フィルタ3よ
りの返送血球と再混合され、その後加温バッグ10で当初
の液温まで加温されつつ、供給源に再び戻される。その
他図中、11はドリップチャンバ、12は圧力検知器、Aは
冷却ゾ−ンである。
On the other hand, the plasma is sent from the plasma supply line 6 to the secondary filter 8 through the cooling coil unit 7 on the line 6 by operating the plasma pump 5, where the plasma is filtered. The plasma is usually cooled to 4 ° C. to 25 ° C., preferably around 4 ° C. in the coil section 7, and the cryogel of a high molecular weight substance generated by this cooling is removed from the plasma by a filtration treatment with a secondary filter. The filtrate from the secondary filter, ie, the purified plasma, is returned to the purified plasma return line 9 while being remixed with the returned blood cells from the primary filter 3 and then heated to the original liquid temperature in the heating bag 10. While returning to the source again. In the figures, 11 is a drip chamber, 12 is a pressure detector, and A is a cooling zone.

ところが、血漿濾過を続けているうちに、2次フィル
タ8は徐々に目詰り傾向となるので、いずれ目詰りを解
消し、機能回復を計ることが必要になる。
However, while the plasma filtration is continued, the secondary filter 8 gradually becomes clogged, so it is necessary to eliminate the clogging and recover the function.

従来、このような目詰り解消法として、 (a)2次フィルタを交換する、 (b)2次フィルタ内を生理食塩水で洗浄する、 等の、二重濾過血漿交換法において採用されている方法
が応用されている。例えば、特公昭63-28626号公報に
は、複数の2次フィルタを並列に接続し、一方が目詰り
したときに他方に切替えるという方法が開示されてい
る。また、特開昭59-129067号公報には、目詰り時に2
次フィルタの内室を大気圧まで降下させ、更に、洗浄液
を2次フィルタの外室側から供給して逆洗浄を行う方法
が示されている。
Conventionally, as such a clogging elimination method, a double filtration plasma exchange method such as (a) replacing a secondary filter, (b) washing the inside of the secondary filter with a physiological saline, and the like has been adopted. The method has been applied. For example, Japanese Patent Publication No. Sho 63-28626 discloses a method in which a plurality of secondary filters are connected in parallel, and when one is clogged, it is switched to the other. Japanese Patent Application Laid-Open No. Sho 59-129067 discloses that when clogging occurs,
A method is shown in which the inner chamber of the next filter is lowered to the atmospheric pressure, and a cleaning liquid is supplied from the outer chamber side of the secondary filter to perform reverse cleaning.

ところが、これら(a)及び(b)の方法は、1回の
洗浄操作で2次フィルタ内に残存している血漿の全量、
例えば約200〜300mlが廃棄される。2次フィルタの洗浄
または交換は、一回の血漿濾過操作で少なくとも2回は
必要であり、ト−タルで少なくとも400〜600mlもの多量
の血漿が系外に廃棄される。その結果、アルブミン製剤
等の高価な薬液の補給が必要になり、経済的負担が増大
すると共に、補給できない物質もあるので、これらの欠
乏を患者にきたすことになり、副作用を生ずる危険性が
ある。その上、複数の2次フィルタを使用する方法で
は、該フイルタは高価なことからその分、治療コストが
嵩むことになる。
However, these methods (a) and (b) require the total amount of plasma remaining in the secondary filter in one washing operation,
For example, about 200 to 300 ml are discarded. Washing or replacement of the secondary filter is required at least twice in one plasma filtration operation, and a large amount of at least 400 to 600 ml of plasma is discarded out of the system. As a result, it is necessary to replenish expensive drug solutions such as albumin preparations, which increases the economic burden and, at the same time, some substances cannot be replenished. . Moreover, in the method using a plurality of secondary filters, the cost of the treatment increases because the filter is expensive.

特に、血漿冷却濾過法では、2次フィルタとして孔径
の比較的大きいものを用いるので、その濾過効率は濾過
開始時が最も低く、クライオゲルが蓄積していくことに
より徐々に効率が上がっていく。従って、上記の方法で
は、切換え又は洗浄操作を行うたびに2次フィルタの濾
過効率がいっぺんに下がってしまうという問題もある。
In particular, in the plasma cooling filtration method, since a filter having a relatively large pore diameter is used as the secondary filter, the filtration efficiency is the lowest at the start of filtration, and the efficiency gradually increases due to accumulation of cryogel. Therefore, in the above method, there is also a problem that the filtering efficiency of the secondary filter is reduced at every switching or cleaning operation.

発明の開示 本発明の1つの目的は、血漿濾過を行なう2次フィル
タを洗浄し再生するに際し、系外に廃棄される血漿の量
を極力少なくできる血漿濾過法及びその装置を提供する
にある。
DISCLOSURE OF THE INVENTION One object of the present invention is to provide a plasma filtration method and apparatus capable of minimizing the amount of plasma discarded outside the system when washing and regenerating a secondary filter for performing plasma filtration.

本発明の他の1つの目的は、上記2次フィルタの洗浄
再生に要する時間並びに洗浄液使用量を低減し得る血漿
濾過法及びその装置を提供するにある。
Another object of the present invention is to provide a plasma filtration method and an apparatus thereof that can reduce the time required for washing and regeneration of the secondary filter and the amount of washing solution used.

本発明の更に他の1つの目的は、上記2次フィルタの
洗浄再生後は、洗浄再生前と殆んど変らない濾過効率の
もとに血漿濾過を再開できる血漿濾過法及びその装置を
提供するにある。
Still another object of the present invention is to provide a plasma filtration method and a plasma filtration method capable of restarting plasma filtration after washing and regeneration of the secondary filter with substantially the same filtration efficiency as before cleaning and regeneration. It is in.

本発明のその他の特徴は以下の記載により明らかにす
る。
Other features of the present invention will become apparent from the following description.

本発明は血液を1次フィルタにて血球と血漿とに分離
し、分離血漿は供給ラインを介し2次フィルタに導き、
該フィルタ内を内室から外室に向け通過させることによ
り、該血漿中より有害成分としての高分子量物質を濾別
して浄化し、浄化血漿は、2次フィルタより返送ライン
を介し、1次フィルタよりの分離血球と混合しつつ血液
として返送する血漿濾過法において、2次フィルタの目
詰り傾向増大にもとづくフィルタ入口側の圧力上昇限界
値を検知するごとに、2次フィルタの内室内を大気中に
開放し圧力降下させる操作と、内室内の圧力降下後に、
2次フィルタ内を、内外両室側から洗浄液を用いて洗浄
しつつ洗浄廃液を内室から系外に排出する操作とを行な
い、これら操作によって2次フィルタの洗浄再生を計っ
た後に、通常運転に戻すことを特徴とする血漿濾過法を
提供する。
The present invention separates blood into blood cells and plasma by a primary filter, and the separated plasma is led to a secondary filter via a supply line,
By passing the inside of the filter from the inner chamber to the outer chamber, a high molecular weight substance as a harmful component is filtered and purified from the plasma, and the purified plasma is returned from the secondary filter via a return line to the primary filter. In the plasma filtration method in which the blood is returned as blood while being mixed with the separated blood cells, every time a pressure increase limit value at the filter inlet side is detected based on an increase in the tendency of the secondary filter to be clogged, the inner space of the secondary filter is exposed to the atmosphere. After releasing the pressure and dropping the pressure inside the chamber,
The inside of the secondary filter is washed from both the inner and outer chambers with the washing liquid while the washing waste liquid is discharged from the inner chamber to the outside of the system, and the cleaning and regeneration of the secondary filter are measured by these operations. The present invention provides a plasma filtration method characterized by returning to the above.

本発明血漿濾過法によれば、2次フィルタの入口側の
圧力が上昇限界値に達すると、該フィルタの内室内が大
気中に開放され、この開放で内室内の圧力が大気圧まで
降下する。
According to the plasma filtration method of the present invention, when the pressure on the inlet side of the secondary filter reaches the rising limit value, the inner chamber of the filter is opened to the atmosphere, and the inner chamber pressure drops to the atmospheric pressure by this opening. .

2次フィルタの内圧内の圧力降下により、該フィルタ
の内,外室間に圧力差を生じ、圧力の高い外室側の浄化
血漿が、圧力の低い内室側に向けて逆流する傾向とな
る。この場合、浄化血漿の返送ラインが開いていると、
逆流傾向は上記ラインの終端側の浄化血液返却部でも生
じ、血液返却部での逆流は好ましくない。血液返却部で
の逆流発生を防止するために、内室内を大気中に開放す
る前に、浄化血漿返送ラインを、好ましくは2次フィル
タ側よりの部分で、一時的に閉じるようにしてもよい。
Due to the pressure drop in the internal pressure of the secondary filter, a pressure difference is generated between the inner and outer chambers of the filter, and the purified plasma in the outer chamber with high pressure tends to flow back toward the inner chamber with low pressure. . In this case, if the return line for purified plasma is open,
The backflow tendency also occurs in the purified blood return section at the end side of the line, and the backflow in the blood return section is not preferable. In order to prevent backflow in the blood return section, the purified plasma return line may be temporarily closed, preferably at the portion from the secondary filter side, before opening the inner chamber to the atmosphere. .

2次フィルタの内,外室間で生ずる逆流傾向により、
内,外室間を仕切っているフィルタ部分が外室側から内
室側に向けて逆流する浄化血漿により予備的に逆洗浄さ
れる。
Due to the backflow tendency between the secondary chamber and the outer chamber,
The filter part that separates the inner and outer chambers is preliminarily backwashed by the purified plasma flowing backward from the outer chamber side to the inner chamber side.

このような内室内の圧力降下操作に引き続き、外室側
に洗浄液が供給され、フィルタ部分の逆洗浄が開始され
ると共に、内室内からも洗浄液が供給され、フィルタ内
室側からの洗浄が開始される。
Following such a pressure drop operation in the inner chamber, the cleaning liquid is supplied to the outer chamber side, the reverse cleaning of the filter portion is started, and the cleaning liquid is also supplied from the inner chamber, and the cleaning from the filter inner chamber side is started. Is done.

本発明によれば、内,外室間の圧力差にもとづく、浄
化血漿による予備的逆洗浄と、内,外両室側からの洗浄
液による洗浄とにより、短時間例えば10秒程度の洗浄操
作で、しかも洗浄液の使用量を少なく、例えば冷却ゾ−
ンの冷却温度が約11〜18℃である場合内,外室を合わせ
て20〜30ml程度の使用量で、2次フィルタの洗浄再生を
計ることができる。
According to the present invention, the preliminary backwashing with the purified plasma based on the pressure difference between the inner and outer chambers and the washing with the washing solution from both the inner and outer chambers can be performed in a short time, for example, about 10 seconds. In addition, the amount of cleaning liquid used is small, for example, a cooling zone.
When the cooling temperature of the filter is about 11-18 ° C, the washing and regeneration of the secondary filter can be performed with the used amount of about 20-30ml in the outside chamber.

2次フィルタの洗浄操作の間には、フィルタ内室内か
ら系外に、洗浄液の使用量、例えば20〜30ml程度に相当
する血漿が廃棄される。
During the operation of washing the secondary filter, plasma equivalent to the used amount of the washing solution, for example, about 20 to 30 ml, is discarded from the inside of the filter to the outside of the system.

2次フィルタ内には通常内,外室を合わせて200〜300
ml程度の血漿が収容されている。本発明において系外に
廃棄される血漿量例えば20〜30mlは、全収容量例えば20
0〜300mlの極く一部にすぎず、全量を系外へ廃棄する従
来法よりも血漿廃棄量を少なくできる。
The inside of the secondary filter is usually 200 to 300
It contains about ml of plasma. In the present invention, the amount of plasma discarded out of the system, e.g.
It is only a very small part of 0 to 300 ml, and the amount of plasma discarded can be reduced as compared with the conventional method in which the entire amount is discarded outside the system.

2次フィルタの洗浄再生は、洗浄液の使用量少なく且
つ短時間で行われるので、フィルタからは目詰り成分
(クライオゲル)は完全には除去されず、一部がそのま
ま残る。従って2次フィルタを新しいものと取換える場
合に見られるような濾過効率の激減は発生せず、濾過性
能を維持させた状態のままで血漿濾過を再開できる。
Since the washing and regeneration of the secondary filter is performed in a short time with a small amount of the washing solution, the clogging component (cryogel) is not completely removed from the filter, and a part thereof remains as it is. Therefore, the filtration efficiency does not drastically decrease as seen when the secondary filter is replaced with a new one, and plasma filtration can be resumed while maintaining the filtration performance.

本発明において、2次フィルタの洗浄操作の間、1次
フィルタから2次フィルタへの血漿供給は、継続しても
よいし、中断してもよい。血漿供給を継続する場合は、
洗浄操作の問も血液ポンプ及び血漿ポンプの駆動を継続
できるので、之等ポンプを洗浄操作ごとに駆動停止させ
るという煩しさがなくなる。また継続すると、洗浄操作
の間に2次フィルタ内に供給された血漿の全量は系外に
廃棄されるので、系外への血漿廃棄量が増加する。増加
量は洗浄操作に要する時間によっても異なるが、例えば
10秒程度の洗浄時間であれば、下記に述べるように4〜
6ml程度であり、この程度の増加であれば特に問題はな
い。勿論、このような血漿廃棄量の増加は、洗浄操作の
間、2次フィルタへの血漿供給を中断することによって
なくし得る。
In the present invention, the plasma supply from the primary filter to the secondary filter may be continued or interrupted during the operation of washing the secondary filter. If you want to continue the plasma supply,
Since the driving of the blood pump and the plasma pump can be continued even in the case of the washing operation, the trouble of stopping the driving of the pump for each washing operation is eliminated. Further, if continued, the entire amount of plasma supplied into the secondary filter during the washing operation is discarded outside the system, and thus the amount of plasma discarded outside the system increases. The amount of increase depends on the time required for the cleaning operation, for example,
If the washing time is about 10 seconds, 4 to
It is about 6 ml, and if there is such an increase, there is no particular problem. Of course, such an increase in plasma waste may be eliminated by interrupting the plasma supply to the secondary filter during the washing operation.

本発明に於ては、2次フィルタの洗浄操作時に生ずる
血漿の系外への廃棄ロスをより一層少なくするために、
2次フィルタの内室内の圧力降下後、洗浄操作を開始す
る前に、血漿回収操作を行なうことができる。
In the present invention, in order to further reduce the waste loss of plasma generated during the washing operation of the secondary filter to the outside of the system,
After the pressure drop in the inner chamber of the secondary filter, a plasma collection operation can be performed before starting the washing operation.

血漿回収操作は、2次フィルタへの血漿供給を中断し
且つ内室内を大気から閉じた状態で、該フィルタ内に洗
浄液を供給し、洗浄液の供給につれ、2次フィルタ内の
血漿を内室から外室を経て、該外室に接続する浄化血漿
返送ライン内に押出し回収することによって行なう。こ
の血漿回収操作は、2次フィルタの内,外室内の血漿の
全量が洗浄液で置換された時点、即ち2次フィルタの内
容量分の洗浄液を供給した時点で終了し、この終了に引
続き、先に述べた2次フィルタの洗浄操作が開始され
る。
In the plasma collection operation, the plasma supply to the secondary filter is interrupted, and the cleaning liquid is supplied into the filter while the inner chamber is closed from the atmosphere, and the plasma in the secondary filter is removed from the inner chamber as the cleaning liquid is supplied. It is carried out by extruding and collecting into the purified plasma return line connected to the outer chamber via the outer chamber. This plasma collection operation is completed when the entire amount of plasma in the outer chamber of the secondary filter has been replaced with the cleaning liquid, that is, when the cleaning liquid corresponding to the inner volume of the secondary filter has been supplied. The washing operation of the secondary filter described in (1) is started.

尚、この場合の2次フィルタの洗浄液量は、2次フィ
ルタの濾過効率が極端に下がらない程度、例えば2次フ
ィルタの内容量程度まで増やしても差支えない。
In this case, the amount of the washing liquid of the secondary filter may be increased to such an extent that the filtration efficiency of the secondary filter is not extremely reduced, for example, to about the internal capacity of the secondary filter.

血漿回収操作は、2次フィルタの目詰り状態で行なわ
れるが、洗浄液例えば生理食塩水は血漿に比べ低粘性で
あるので、フィルタ内を容易に通過できる。
The plasma collection operation is performed in a state where the secondary filter is clogged. However, since the washing liquid, for example, physiological saline has a lower viscosity than the plasma, it can easily pass through the filter.

血漿回収操作の間、血液ポンプ及び血漿ポンプの駆動
を停止させることなく、血漿を供給ラインから2次フィ
ルタと並列するバイパスラインを介し返送ライン側に循
環させてもよい。
During the plasma collection operation, the plasma may be circulated from the supply line to the return line via a bypass line parallel to the secondary filter without stopping the operation of the blood pump and the plasma pump.

血漿回収操作を行なう場合、2次フィルタの内,外室
内には、血漿と置換された洗浄液が充満し、従って洗浄
操作後に、直ちに通常運転に戻すと、内,外室内の全量
の洗浄液がそのまま返送ライン側に入る。
When performing the plasma collection operation, the inner and outer chambers of the secondary filter are filled with the washing liquid that has been replaced with plasma. Therefore, if the operation is immediately returned to the normal operation after the washing operation, the entire amount of the washing liquid in the inner and outer chambers remains unchanged. Enter the return line side.

本発明に於ては、返送ライン側に入る洗浄液量を少な
くするために、2次フィルタの洗浄操作後、通常運転に
戻す前に、洗浄液の系外への排出操作を行なうことがで
きる。
In the present invention, in order to reduce the amount of the washing liquid entering the return line, after the washing operation of the secondary filter, the washing liquid can be discharged out of the system before returning to the normal operation.

洗浄液の排出操作は、2次フィルタの内室を大気中に
開放し且つ返送ラインを閉じた状態で該フィルタの内室
内に血漿を供給し、血漿供給につれ、内室内の洗浄液を
系外に排出することによって行なう。この排出操作は、
内室内の洗浄液の全量が血漿で置換された時点で終了
し、この終了後に通常運転に戻される。このような洗浄
液の排出操作を行なうことにより、通常運転時に返送ラ
イン側に入る洗浄液量はフィルタの外室の容積相当分と
なり、内室の容積相当分だけ減ることになる。
In the operation of discharging the cleaning liquid, plasma is supplied to the inner chamber of the secondary filter with the inner chamber of the secondary filter opened to the atmosphere and the return line closed, and the cleaning liquid in the inner chamber is discharged out of the system as the plasma is supplied. By doing it. This ejection operation
The operation ends when the entire amount of the washing liquid in the inner chamber is replaced with plasma, and after this operation, the operation is returned to the normal operation. By performing such a cleaning liquid discharging operation, the amount of the cleaning liquid entering the return line side during the normal operation is equivalent to the volume of the outer chamber of the filter, and is reduced by the volume of the inner chamber.

図面の簡単な説明 図1は本発明血漿濾過法の実施に使用される装置の1
例を示すフロ−チャ−トである。
BRIEF DESCRIPTION OF THE DRAWINGS FIG. 1 shows one of the devices used to carry out the plasma filtration method of the present invention.
It is a flowchart showing an example.

図2は図1における2次フィルタの構造説明のための
模式図である。
FIG. 2 is a schematic diagram for explaining the structure of the secondary filter in FIG.

図3は本発明血漿濾過法の実施に使用される装置の他
の1例を示すフロ−チャ−トである。
FIG. 3 is a flowchart showing another example of the apparatus used for carrying out the plasma filtration method of the present invention.

図4は従来法の説明のためのフロ−チャ−トである。 FIG. 4 is a flowchart for explaining the conventional method.

発明を実施するための最良の形態 以下に本発明血漿濾過法を添附図面にもとづき説明す
ると次の通りである。
BEST MODE FOR CARRYING OUT THE INVENTION The plasma filtration method of the present invention is described below with reference to the accompanying drawings.

図1は本発明血漿濾過法の実施に適用される装置の1
例を示すフロ−チャ−トであり、図4の従来装置と共通
する部分は共通の参照番号で示されている。
FIG. 1 shows one of the devices applied to carry out the plasma filtration method of the present invention.
4 is a flowchart showing an example, and portions common to the conventional device of FIG. 4 are indicated by common reference numerals.

図1に示す本発明実施のための装置は、図4に示す従
来装置の構成に加え、血漿供給ライン6上の2次フィル
タ8側よりに設置された圧力検知器13と、一端が2次フ
ィルタ8の下端でその内室に接続し他端が大気中に開口
する弁14a付廃液ライン14と、一端が2次フィルタ8の
手前で血漿供給ライン6に接続し他端が集合ライン17を
介し洗浄液供給源18に接続する弁15a付洗浄液供給ライ
ン15と、一端が2次フィルタ8の側壁上部でその外室に
接続し他端が集合ライン17を介し洗浄液供給源18に接続
する弁16a付洗浄液供給ライン16と、浄化血漿返送ライ
ン9上の2次フィルタ8側よりに設置された弁23とが備
えられている。
The apparatus for implementing the present invention shown in FIG. 1 has a pressure detector 13 installed from the side of the secondary filter 8 on the plasma supply line 6 in addition to the configuration of the conventional apparatus shown in FIG. A waste liquid line 14 with a valve 14a connected to the inner chamber at the lower end of the filter 8 and open at the other end to the atmosphere, and one end connected to the plasma supply line 6 before the secondary filter 8 and the other end connected to the collecting line 17 A cleaning liquid supply line 15 with a valve 15a connected to the cleaning liquid supply source 18 via a valve, and a valve 16a having one end connected to the outer chamber at the upper part of the side wall of the secondary filter 8 and the other end connected to the cleaning liquid supply source 18 via the collecting line 17 A washing liquid supply line 16 is provided, and a valve 23 installed on the purified plasma return line 9 from the secondary filter 8 side.

圧力検知器13は、目詰り傾向増大にもとづく2次フィ
ルタ8の入口部の圧力上昇限界値を検知する手段として
の働きと、2次フィルタ8の内室内の圧力降下限界値を
検知する手段としての働きをする。このような圧力検知
は、上記検知器13に代え、供給ライン6上のドリップチ
ャンバ−11に備えられている圧力検知器12で行うように
してもよい。
The pressure detector 13 functions as a means for detecting a pressure rise limit value at the inlet of the secondary filter 8 based on an increase in the tendency of clogging, and as a means for detecting a pressure drop limit value in the inner chamber of the secondary filter 8. Works. Such pressure detection may be performed by the pressure detector 12 provided in the drip chamber 11 on the supply line 6 instead of the detector 13.

弁14a付廃液ライン14は、内室内を大気中に開放し圧
力降下させる手段としての働きと、内室内から洗浄廃液
を系外に排出する手段としての働きとする。
The waste liquid line 14 with the valve 14a functions as a means for opening the inner chamber to the atmosphere to lower the pressure, and as a means for discharging the cleaning waste liquid from the inner chamber to the outside of the system.

弁15a、16a付洗浄液供給ライン15、16は、内室内の圧
力降下後に、2次フィルタ8内を内,外両室側から同時
洗浄する手段としての働きをする。
The cleaning liquid supply lines 15 and 16 with the valves 15a and 16a function as means for simultaneously cleaning the inside of the secondary filter 8 from both the inner and outer chambers after the pressure in the inner chamber drops.

浄化血漿の返送ライン9上の弁23は、2次フィルタ8
内の圧力降下操作を、該ライン9を閉じた状態で行なう
ために備えたものであり、通常運転時は、開状態を保持
する。
The valve 23 on the return line 9 for the purified plasma is
In order to perform the pressure drop operation inside the line 9 while the line 9 is closed, the line 9 is kept open during normal operation.

図2は2次フィルタ8の構造を説明するための模式図
である。2次フィルタ8は通常セルロ−スジアセテ−
ト、ポリビニルアルコ−ル、ポリエチレン、ポリプロピ
レン、ポリスルホン、EVAL、PMMA(ポリメチルメタアク
リレ−ト)、PAN(ポリアクリロニトリル)などによっ
て作られたホロ−ファイバ(中空糸)を数千本内蔵し、
図では便宜上ホロ−ファイバ19の一本を拡大し模式化し
て示している。上記ホロ−ファイバ19の孔径は特に制限
はなく、通常は0.01〜0.5μの範囲から血漿冷却の程度
を考慮して選択される。1次フィルタ3にも2次フィル
タと同様にホロ−ファイバが適用され、該ファイバの孔
径は血球を濾別できる程度であればよく、0.2〜0.6μ前
後が適当である。
FIG. 2 is a schematic diagram for explaining the structure of the secondary filter 8. The secondary filter 8 is usually a cellulose diacetate.
Thousands of hollow fibers (hollow fibers) made of fiber, polyvinyl alcohol, polyethylene, polypropylene, polysulfone, EVAL, PMMA (polymethyl methacrylate), PAN (polyacrylonitrile), etc.
In the figure, one of the hollow fibers 19 is enlarged and schematically shown for convenience. The hole diameter of the hollow fiber 19 is not particularly limited, and is usually selected from the range of 0.01 to 0.5 µ in consideration of the degree of plasma cooling. A hollow fiber is applied to the primary filter 3 as well as the secondary filter, and the hole diameter of the fiber is only required to be able to filter blood cells, and is suitably about 0.2 to 0.6 μm.

図2に細線矢符20で示ように通常の血漿濾過運転時に
於ては、血漿は1次フィルタ(図1参照)から血漿供給
ライン6及び該ライン6上の冷却コイル部7を通って2
次フィルタ8内蔵のホロ−ファイバ19の内室部19a内、
即ち該フィルタ8の内室8a内に通常ト−タルで毎秒当た
り0.4〜0.6ml程度の流量で流入する。
As shown by the thin arrow 20 in FIG. 2, during a normal plasma filtration operation, plasma is passed from the primary filter (see FIG. 1) through the plasma supply line 6 and the cooling coil section 7 on the line 6 to the plasma.
In the inner chamber portion 19a of the hollow fiber 19 with the built-in next filter 8,
That is, the filter 8 generally flows into the inner chamber 8a of the filter 8 at a flow rate of about 0.4 to 0.6 ml per second by a total.

内腔部19a内に流入した血漿中には冷却コイル部7及
び2次フィルタ8における冷却で高分子量物質のゲル化
物、所謂クライオゲルが発生しており、このクライオゲ
ルは上記ファイバ19の肉厚部19bの通過時に該肉厚部19b
で捕捉され、血漿成分だけが肉厚部19bを通過する。肉
厚部19bの通過で浄化された血漿は、常法通り、肉厚部1
9bの外側、即ち2次フィルタ8の外室8bからこれに接続
している返送ライン9に向け流出していく。
In the plasma flowing into the lumen 19a, a gelled substance of a high molecular weight substance, a so-called cryogel is generated by cooling in the cooling coil section 7 and the secondary filter 8, and this cryogel is a thick section 19b of the fiber 19. Thick portion 19b when passing
And only the plasma component passes through the thick portion 19b. The plasma purified by passing through the thick portion 19b is separated from the thick portion 1b as usual.
It flows out of the outside 9b, that is, from the outer chamber 8b of the secondary filter 8 to the return line 9 connected thereto.

上記ファイバ19の肉厚部19bで捕捉されたクライオゲ
ルは、その内部及び内腔部19a側表面に経時的に蓄積し
て行き、この蓄積でファイバ19の内腔部19aひいてはフ
ィルタ内室8a内の圧力は通常運転時の0〜20mmHg徐々に
上昇して行き、この圧力上昇は検知器13により検知され
る。
The cryogel captured by the thick portion 19b of the fiber 19 accumulates over time on the inside thereof and on the surface on the side of the cavity portion 19a, and the accumulation causes the inside of the cavity portion 19a of the fiber 19 and eventually the inside of the filter inner chamber 8a. The pressure gradually increases from 0 to 20 mmHg during normal operation, and this pressure increase is detected by the detector 13.

検知器13にて検知される圧力が限界値例えば約300mmH
gに達すると、廃液ライン14上の弁14aが閉→開となり、
よってファイバ19の内腔部19aひいてはフィルタ内室8a
内の圧力は大気圧まで降下する。この圧力降下で、目詰
りを生じている肉厚部19bを挟んでその内側の内腔部19a
ひいてはフィルタ内室8aと、その外側のフィルタ外室8b
との間に圧力差を生じ、この圧力差で外室8b内に充満し
ている処理剤の浄化血漿が内室8a側に向け逆流傾向とな
り、よって肉厚部19bは、この逆流傾向により予備的に
逆洗浄される。
The pressure detected by the detector 13 is a limit value, for example, about 300 mmH
g, the valve 14a on the waste liquid line 14 changes from closed to open,
Therefore, the inner cavity portion 19a of the fiber 19, and thus the filter inner chamber 8a
The pressure inside drops to atmospheric pressure. Due to this pressure drop, the lumen 19a inside the thick portion 19b clogging is sandwiched.
Eventually, the filter inner chamber 8a and the filter outer chamber 8b outside thereof
And the purified plasma of the processing agent filled in the outer chamber 8b tends to flow back toward the inner chamber 8a due to the pressure difference. Is backwashed.

浄化血漿の逆流傾向が、返送ライン9の終端側まで波
及すると、該ライン9の終端側の浄化血液返却部分で血
液の逆流が起こることになり、好ましくない。このよう
な血液の逆流傾向は、上記ライン14上の弁14aが閉→開
になる前に返送ライン9上の弁23を開→閉にすることに
より防止できる。
If the tendency of the backflow of the purified plasma spreads to the terminal side of the return line 9, the backflow of blood occurs at the purified blood return portion at the terminal side of the return line 9, which is not preferable. Such a tendency of the backflow of blood can be prevented by opening and closing the valve 23 on the return line 9 before the valve 14a on the line 14 is closed and opened.

内腔部19aひいてはフィルタ内室8a内の圧力降下は上
記検知器13により検知され、圧力降下と同時に或いは僅
かの時間差をおいて、フィルタ外室8b側に接続している
洗浄液供給ライン16上の弁16aが閉→開となる。よって
洗浄液がその供給源18から集合ライン17及び供給ライン
16を順次経て外室8b内に例えばポンプ駆動(図示せず)
又は落差を利用して供給される。このフィルタ外室8b内
への洗浄液の供給により矢符21で示すように肉厚部19b
は逆洗浄される。洗浄液によるフィルタの逆洗浄は、通
常2次フィルタ8への分離血漿の供給を継続した状態の
まま行なわれ、この逆洗浄の間、ライン6より2次フィ
ルタ8内に送られてくる血漿は廃液ライン14を通じ系外
に排出されて行くので、逆洗浄はできるだけ短時間で速
やかに行なうことが必要である。また逆洗浄の間、洗浄
液の使用量に略々相当する血漿量が内腔部9a(又は内室
8a)から廃液ライン14を通じ系外に排出されるので、洗
浄液の使用量もできるだけ少なくする必要が生じる。
The pressure drop in the inner cavity portion 19a and thus in the filter inner chamber 8a is detected by the detector 13, and at the same time as the pressure drop or with a slight time lag, the cleaning liquid supply line 16 connected to the filter outer chamber 8b side The valve 16a changes from closed to open. Therefore, the cleaning liquid is supplied from the supply source 18 to the collecting line 17 and the supply line.
For example, a pump is driven (not shown) into the outer chamber 8b through the sequence 16
Or it is supplied using a head. The supply of the cleaning liquid into the filter outer chamber 8b causes the thick portion 19b to be
Is backwashed. The back washing of the filter with the washing liquid is usually performed while the supply of the separated plasma to the secondary filter 8 is continued. During this back washing, the plasma sent from the line 6 into the secondary filter 8 is a waste liquid. Since the water is discharged out of the system through the line 14, the backwashing needs to be performed as quickly as possible in a short time. In addition, during the backwashing, the amount of plasma substantially corresponding to the amount of the washing solution is used in the lumen 9a (or the inner chamber).
Since it is discharged out of the system through the waste liquid line 14 from 8a), it is necessary to reduce the usage amount of the cleaning liquid as much as possible.

更に、とりわけ血漿冷却濾過法に於ては、肉厚部19b
に幾分グライオゲルが存在している状態の方がフィルタ
の濾過効率がよいので、洗浄液の使用量を多くしすぎる
と肉厚部19bのクライオゲルが無くなってしまい、フィ
ルタの濾過効率が一挙に低下してしまう。ところが逆洗
浄用の洗浄液の使用量を少なくすると、逆洗浄により肉
厚部19bから遊離したクライオゲルを十分完全に洗い流
すことができなくなる。ちなみに内腔部19a内には、常
時処理前血漿がト−タルで毎秒当り0.4〜0.6ml流れてい
るが、あまりにも少量すぎるためクライオゲルを洗い流
すには十分でない。
Furthermore, especially in the plasma cooling filtration method, the thick portion 19b
Since the filtration efficiency of the filter is better in the state where some amount of gliogel is present, the cryogel in the thick portion 19b will be lost if the amount of the cleaning liquid used is too large, and the filtration efficiency of the filter will be reduced at once. Would. However, when the amount of the cleaning solution used for back washing is reduced, the cryogel released from the thick portion 19b due to the back washing cannot be sufficiently and completely washed away. Incidentally, the plasma before treatment always flows in the lumen portion 19a by a total of 0.4 to 0.6 ml per second in total, but it is too small to wash out the cryogel.

そこで本発明では、逆洗浄用の洗浄液供給ライン16上
の弁16aが閉→開となると同時に或いは2〜3秒程度の
時間差をおいて、フィルタ内室8a側に接続している洗浄
液供給ライン15の弁15aが閉→開となり、逆洗浄の間、
逆洗浄用と略々同量の洗浄液を該ライン15から血漿供給
ライン6を通じ内室8a内即ち内腔部19a内に供給してい
る。
Therefore, in the present invention, the cleaning liquid supply line 15 connected to the filter inner chamber 8a side at the same time as the valve 16a on the cleaning liquid supply line 16 for back cleaning is closed → open or with a time difference of about 2 to 3 seconds. Valve 15a is closed → open, and during backwashing,
Approximately the same amount of washing liquid as that for back washing is supplied from the line 15 through the plasma supply line 6 into the inner chamber 8a, that is, into the inner cavity 19a.

内腔部19a内に流入した洗浄液は図2に太線矢符22で
示すように、該部19a内を常時流通している処理前血漿
と協同して、クライオゲルを内腔部19aの内壁部分から
洗い流しつつ廃液ライン14から系外に排出される。
As shown by the bold arrow 22 in FIG. 2, the washing liquid flowing into the inner cavity 19a cooperates with the unprocessed plasma constantly flowing through the inner cavity 19a to remove the cryogel from the inner wall portion of the inner cavity 19a. It is discharged from the waste liquid line 14 outside the system while being washed away.

本発明によれば、内外室8a,8b間の圧力差にもとづく
処理済血漿の予備的逆洗浄と、内外両室側からの洗浄液
による同時洗浄とにより、短時間例えば10秒程度の洗浄
操作で、しかも洗浄液の使用量を極く少なくして、例え
ば全量で20ml程度の使用量でフィルタの目詰りを解消で
きる。
According to the present invention, the preliminary back washing of the treated plasma based on the pressure difference between the inner and outer chambers 8a and 8b and the simultaneous washing with the washing liquid from both the inner and outer chambers can be performed in a short time, for example, about 10 seconds. In addition, the amount of the cleaning liquid used is extremely small, and for example, clogging of the filter can be eliminated with a total usage of about 20 ml.

所定時間の洗浄操作を終えた後は各ライン14,15,16上
の開閉弁14a,15a,16aが開→閉となり一方ライン9上の
弁23が閉→開となり、再び通常の濾過運転に戻る。
After the completion of the washing operation for a predetermined time, the on-off valves 14a, 15a, 16a on the lines 14, 15, 16 are changed from open to closed, while the valve 23 on the line 9 is changed from open to closed. Return.

このようなフィルタの目詰り解消操作は圧力検知器13
を主指標として繰り返され、1回の血漿濾過操作で、経
験的には約4回の目詰り解消操作が行なわれる。
The operation to clear the clogged filter is performed by the pressure detector 13.
Is repeated as a main index, and one plasma filtration operation is empirically performed about four times to eliminate clogging.

本発明において、1回の目詰り解消操作で系外に廃棄
される血漿量は、洗浄液の全使用量に相当する約20ml
と、連続的に送られてくる処理前血漿の4〜6ml(0.4〜
0.6ml×10秒)であり、全体で24〜26mlであるので、4
回の繰返しでは96〜104mlとなる。これを従来法の400〜
600mlと比較すると遥かに少なく、血漿の系外への廃棄
量を1/5程度に低減し得る。
In the present invention, the amount of plasma discarded outside the system in one clogging operation is about 20 ml corresponding to the total amount of the washing solution.
And 4 to 6 ml of pre-processed plasma continuously sent (0.4 to
0.6 ml x 10 seconds), and the total amount is 24-26 ml.
The number of repetitions is 96 to 104 ml. This is 400-
Compared to 600 ml, it is much less, and the amount of plasma discarded outside the system can be reduced to about 1/5.

尚、1回の洗浄に用いる洗浄液の量や1回の洗浄時間
を、上記より少なくした場合でも、洗浄回数を増やすこ
とによって、同様の効果を得ることができ、1回当たり
の洗浄液量を若干増やした場合は、その分洗浄回数を減
らすことにより対応できる。
Even when the amount of the cleaning liquid used for one cleaning and the time for one cleaning are shorter than those described above, the same effect can be obtained by increasing the number of cleanings, and the amount of the cleaning liquid per one time can be slightly reduced. When the number of washings is increased, it can be dealt with by reducing the number of washings.

2次フィルタ8の洗浄再生の間、2次フィルタへの血
漿供給は継続してもよいし、中断してもよい。既に述べ
たように2次フィルタへの血漿供給を継続する場合は洗
浄再生操作の間もポンプ1及び5の駆動を継続できる。
従って洗浄再生操作ごとにポンプ1及び5の駆動を停止
させるという煩しさがなくなる。一方血漿供給を中断す
る場合は、洗浄操作の間、2次フィルタ8には血漿が供
給されなくなるので、その分系外への血漿の廃棄ロス量
を少なくできる。
During the washing and regeneration of the secondary filter 8, the supply of plasma to the secondary filter may be continued or interrupted. As described above, when the supply of plasma to the secondary filter is continued, the driving of the pumps 1 and 5 can be continued even during the washing and regeneration operation.
Therefore, the trouble of stopping the driving of the pumps 1 and 5 for each cleaning and regenerating operation is eliminated. On the other hand, when the supply of the plasma is interrupted, the plasma is not supplied to the secondary filter 8 during the washing operation, so that the amount of loss of the plasma outside the system can be reduced.

本発明においては、2次フィルタ8の洗浄再生操作を
自動制御のもとに行うために、弁14a,15a,16a,23とし
て、電磁弁を用いることができる。自動制御の一例を簡
単に述べると、通常運転、即ち弁14a,15a,16aは閉、弁2
3は開の状態で圧力検知器13が圧力上昇限界値を検知す
ると、この検知信号を受けて、弁23が開→閉、弁14aが
閉→開となり、圧抜きが行なわれる。この圧抜きで検知
器13が圧力降下限界値を検知すると、この検知信号を受
けて、弁15a,16aが閉→開となり、洗浄が開始される。
洗浄開始後、所定時間が経過すると、タイマ−などの働
きで、弁14a,15a,16aが開→閉となり、一方弁23が閉→
開となり、通常運転に戻る。
In the present invention, an electromagnetic valve can be used as the valves 14a, 15a, 16a, and 23 in order to perform the cleaning and regeneration operation of the secondary filter 8 under automatic control. To briefly describe an example of automatic control, normal operation, that is, valves 14a, 15a, and 16a are closed and valve 2 is closed
3, when the pressure detector 13 detects the pressure rise limit value in the open state, receiving this detection signal, the valve 23 is opened → closed, the valve 14a is closed → open, and the pressure is released. When the detector 13 detects the pressure drop limit value by this pressure release, receiving this detection signal, the valves 15a and 16a are changed from the closed state to the open state, and the washing is started.
After a predetermined time elapses after the start of washing, the valves 14a, 15a, 16a are opened → closed by the action of a timer or the like, while the valve 23 is closed →
It opens and returns to normal operation.

図3は本発明血漿濾過法を実施するに適した装置の他
の1例を示している。
FIG. 3 shows another example of an apparatus suitable for performing the plasma filtration method of the present invention.

図3に示された本発明装置は、図1に示されている圧
抜き手段及び洗浄手段に加え、血漿回収手段、洗浄液排
出手段及び処理前血漿循環手段とを備えている。
The apparatus of the present invention shown in FIG. 3 includes, in addition to the depressurizing means and the washing means shown in FIG. 1, a plasma collecting means, a washing liquid discharging means, and a pre-treatment plasma circulating means.

血漿回収手段は、2次フィルタ8の内室の圧抜き後、
洗浄操作に入る前に、2次フィルタの内,外室内の血漿
を返送ライン9側に回収するためのものである。
The plasma collection means, after depressurizing the inner chamber of the secondary filter 8,
Before the washing operation, the plasma in the outer chamber of the secondary filter is collected on the return line 9 side.

洗浄液排出手段は、2次フィルタ8の洗浄後、通常運
転に戻る前に、内,外室内に残っている洗浄液のうち、
内室内の洗浄液を系外に排出するためのものである。
After the secondary filter 8 has been washed and before returning to the normal operation, the washing liquid discharging means is provided for cleaning the remaining washing liquid in the inner and outer chambers.
This is for discharging the cleaning liquid in the inner chamber to the outside of the system.

処理前血漿循環手段は、上記各種操作において、2次
フィルタ8への血漿供給が中断している間、血漿を供給
ラインから返送ライン9へ循環させるためのものであ
る。
The pre-treatment plasma circulating means is for circulating the plasma from the supply line to the return line 9 while the supply of the plasma to the secondary filter 8 is interrupted in the above various operations.

上記の各種手段を構成するために、図3に示す装置で
は、図1に示す装置の構成に加え、血漿供給ライン6上
に設置された弁24、集合ライン17上に設置された洗浄液
ポンプ26、上記弁24より1次フィルタ3側で供給ライン
6を返送ライン9に接続する弁25a付バイパスライン25
を備えている。各種手段の構成要素は一部共用されてい
る。
In order to configure the various means described above, in the apparatus shown in FIG. 3, in addition to the configuration of the apparatus shown in FIG. 1, a valve 24 installed on the plasma supply line 6 and a washing liquid pump 26 installed on the collecting line 17 are used. A bypass line 25 with a valve 25a connecting the supply line 6 to the return line 9 on the primary filter 3 side from the valve 24.
It has. Some components of the various means are shared.

図3に示された装置を適用して、本発明血漿濾過法を
実施するに際し、2次フィルタ8の洗浄再生操作の1サ
イクルを示すと次の通りである。
One cycle of the washing and regenerating operation of the secondary filter 8 when performing the plasma filtration method of the present invention by applying the apparatus shown in FIG. 3 is as follows.

上記、1サイクルの各操作時に於ける弁の開閉位置
は、次の通りである。
The open / close position of the valve during each operation in one cycle is as follows.

〔通常運転時〕(During normal operation)

開位置…弁24、23 閉位置…弁14a,25a,15a,16a 〔圧抜き操作時〕 開位置…弁24、14 閉位置…弁23,25a,15a,16a 〔血漿回収操作時〕 開位置…弁23、25a,15a 閉位置…弁24,14a,16a 〔洗浄操作時〕 開位置…弁25a,15a,16a,14a 閉位置…弁24,23 〔洗浄液排出操作時〕 開位置…弁24、14a 閉位置…弁25a,15a,16a,23 上記各操作のうち、圧抜き操作並びに洗浄操作は、図
1の場合と実質的に同じである。
Open position: Valves 24, 23 Closed position: Valves 14a, 25a, 15a, 16a [During pressure release operation] Open position: Valves 24, 14 Closed position: Valves 23, 25a, 15a, 16a [During plasma collection operation] Open position … Valves 23, 25a, 15a Closed position… Valves 24, 14a, 16a [For cleaning operation] Open position… Valves 25a, 15a, 16a, 14a Closed position… Valves 24, 23 [For cleaning liquid discharge operation] Open position… Valve 24 , 14a closed position ... valves 25a, 15a, 16a, 23 Of the above operations, the depressurizing operation and the washing operation are substantially the same as those in FIG.

以下に血漿回収操作並びに洗浄液排出操作につき、図
3を参照しつつ説明する。
Hereinafter, the plasma collecting operation and the washing liquid discharging operation will be described with reference to FIG.

血漿回収操作は弁24を閉じ、処理前血漿の2次フィル
タ8への供給を中断した状態で行なわれる。この中断の
間ポンプ1及び5の駆動を継続するために、バイパスラ
イン25が開き、上記血漿は供給ライン6→バイパスライ
ン25→返送ライン9へと循環される。
The plasma collection operation is performed with the valve 24 closed and the supply of the pre-processed plasma to the secondary filter 8 interrupted. In order to continue driving the pumps 1 and 5 during this interruption, the bypass line 25 is opened, and the plasma is circulated from the supply line 6 → the bypass line 25 → the return line 9.

一方ポンプ26の駆動で洗浄液がライン15から2次フィ
ルタ8の内室内に供給され、この洗浄液の供給につれ、
内,外室内の血漿が外室からこれに接続する返送ライン
9内に押し出されて行き、回収される。
On the other hand, the cleaning liquid is supplied from the line 15 into the inner chamber of the secondary filter 8 by the drive of the pump 26, and as the cleaning liquid is supplied,
The plasma in the inner and outer chambers is pushed out of the outer chamber into a return line 9 connected thereto and collected.

内室内への洗浄液の供給は2次フィルタ8の目詰り状
態で行なわれるが、洗浄液は通常生理食塩水であり、血
漿に比べ低粘性であるので、目詰り状態のフィルタ内を
内室から外室に向け通過できる。
The supply of the washing liquid into the inner chamber is performed while the secondary filter 8 is clogged. However, since the washing liquid is usually physiological saline and has a lower viscosity than plasma, the inside of the clogged filter is removed from the inner chamber. Can pass to the room.

内室内への洗浄液の供給の間、圧力検出器13が圧力上
昇限界値を検知した時は、洗浄液の供給を一時的に中断
し又は中断することなしに、弁14aを閉→開となし、圧
抜き操作を行えばよい。
During the supply of the cleaning liquid to the inner chamber, when the pressure detector 13 detects the pressure rise limit value, the valve 14a is closed → opened without temporarily or without interrupting the supply of the cleaning liquid, What is necessary is just to perform a pressure relief operation.

内室内への洗浄液の供給は、内,外室内への全血漿が
洗浄液と置換されるまで継続される。2次フィルタ8の
内容積は予め判っているので、例えば上記ライン15上に
備えた流量計(図示せず)で流量を計ることにより、置
換終了時点が判る。置換が終了すると、先に述べたよう
に洗浄操作に入る。
The supply of the washing liquid into the inner chamber is continued until all the plasma into the inner and outer chambers is replaced with the washing liquid. Since the internal volume of the secondary filter 8 is known in advance, the end point of the replacement can be determined by measuring the flow rate with a flow meter (not shown) provided on the line 15, for example. When the replacement is completed, the washing operation is started as described above.

洗浄操作に入る前に、内,外室内の全血漿を洗浄液と
置換し返送ライン9側に回収しておくことにより、洗浄
操作時に於ける系外への血漿廃棄ロスを実質的になくし
得る。
By replacing all the plasma in the inner and outer chambers with the washing solution and collecting it on the return line 9 side before starting the washing operation, the plasma disposal loss outside the system during the washing operation can be substantially eliminated.

洗浄操作後に、2次フィルタ8の内外室内に残る液
は、実質的に全てが洗浄液である。これは洗浄操作前に
内外室内から全血漿が洗浄液との置換で回収されている
からである。従って洗浄操作後にすぐに通常運転に戻る
と、内,外室内の全ての洗浄液が返送ライン9内に入
る。
Substantially all of the liquid remaining in the inner and outer chambers of the secondary filter 8 after the cleaning operation is the cleaning liquid. This is because the whole plasma was recovered from the inside and outside chambers by the replacement with the washing solution before the washing operation. Therefore, when the operation returns to the normal operation immediately after the cleaning operation, all the cleaning liquid in the inner and outer chambers enters the return line 9.

返送ライン9内に入る洗浄液量はできるだけ少ない方
がよく、この目的で、洗浄操作に引続き、洗浄液の排出
操作が行なわれる。
It is preferable that the amount of the cleaning liquid entering the return line 9 is as small as possible. For this purpose, the cleaning liquid is discharged following the cleaning operation.

洗浄液排出操作時は、弁24,14aが開き、他の弁は全て
閉じている。従って血漿回収操作並びに洗浄操作の間、
バイパスライン25側に流れていた血漿は、弁24開により
2次フィルタ8の内室内に入り、これに代って廃液ライ
ン14からは洗浄液が排出されて行く。2次フィルタ8へ
の血漿の毎秒当りの供給量は判っているので、所定時間
が経過し、内室内の全洗浄液が血漿と置換された後、例
えばタイマ−などの働きで、弁14aを開→閉、弁23を閉
→開にすることにより、通常運転に戻る。
During the cleaning liquid discharging operation, the valves 24 and 14a are open, and all other valves are closed. Therefore, during the plasma collection operation and the washing operation,
The plasma flowing to the bypass line 25 side enters the inner chamber of the secondary filter 8 by opening the valve 24, and the washing liquid is discharged from the waste liquid line 14 instead. Since the supply amount of plasma per second to the secondary filter 8 is known, after a predetermined time has elapsed and all the washing liquid in the inner chamber has been replaced with plasma, the valve 14a is opened by, for example, a timer or the like. Return to normal operation by closing → closing valve 23 → opening.

図3に示された装置においても、図1の場合と同様
に、各操作時に於ける弁の開閉を自動制御するために、
弁として電磁弁を用いることができる。
In the apparatus shown in FIG. 3, as in the case of FIG. 1, in order to automatically control the opening and closing of the valve at each operation,
A solenoid valve can be used as the valve.

───────────────────────────────────────────────────── フロントページの続き (72)発明者 鴨川 弘 徳島県板野郡松茂町満穂字満穂開拓96― 1 (56)参考文献 特開 昭59−11865(JP,A) 特開 昭63−127765(JP,A) (58)調査した分野(Int.Cl.6,DB名) A61M 1/02 540 A61M 1/34 500 A61M 1/36 540 ──────────────────────────────────────────────────続 き Continuation of the front page (72) Inventor Hiroshi Kamogawa 96-1, Mitsuho, Matsumo-cho, Itano-gun, Tokushima Prefecture (56) References JP-A-59-11865 (JP, A) JP-A-63-127765 ( JP, A) (58) Field surveyed (Int. Cl. 6 , DB name) A61M 1/02 540 A61M 1/34 500 A61M 1/36 540

Claims (6)

(57)【特許請求の範囲】(57) [Claims] 【請求項1】血液を1次フィルタにて血球と血漿とに分
離し、分離血漿は供給ラインを介し2次フィルタに導
き、該フィルタ内を内室から外室に向け通過させること
により、該血漿中より有害成分としての高分子量物質を
濾別して浄化し、浄化血漿は2次フィルタより返送ライ
ンを介し、1次フィルタよりの分離血球と混合しつつ血
液として返送する血漿濾過装置に於て、2次フィルタの
入口部内の圧力上昇限界値を検知する手段と、同内室内
の圧力降下限界値を検知する手段と、上記手段が圧力上
昇限界値を検知するごとに内室内を大気中に開放し内室
内の圧力を降下させる手段と、上記手段が内室内の圧力
降下限界値を検知するごとに、2次フィルタ内に内,外
両室側から洗浄液を供給する手段とを備えていることを
特徴とする血漿濾過装置。
1. A method according to claim 1, wherein the blood is separated into blood cells and plasma by a primary filter, and the separated plasma is led to a secondary filter via a supply line, and passes through the filter from an inner chamber to an outer chamber. In a plasma filtration device that filters and purifies high molecular weight substances as harmful components from plasma and purifies the purified plasma through a return line from a secondary filter and returns as blood while mixing with separated blood cells from the primary filter. Means for detecting the pressure rise limit value in the inlet of the secondary filter, means for detecting the pressure drop limit value in the inner chamber, and opening of the inner chamber to the atmosphere each time the means detects the pressure rise limit value. Means for lowering the pressure in the inner chamber, and means for supplying a cleaning liquid from the inner and outer chambers in the secondary filter each time the means detects a pressure drop limit value in the inner chamber. Plasma filtration characterized by Location.
【請求項2】2次フィルタでの血漿の濾過を冷温状態で
行なうための冷却ゾ−ンが設置されていることを特徴と
する請求の範囲第1項記載の血漿濾過装置。
2. A plasma filtering apparatus according to claim 1, further comprising a cooling zone for performing filtration of the plasma by a secondary filter in a cold state.
【請求項3】浄化血漿の返送ライン上に、2次フィルタ
の内室内の圧力降下時に閉じ、通常運転に戻ると開く、
弁が備えられていることを特徴とする請求の範囲第1項
又は第2項記載の濾過装置。
3. A return line for the purified plasma, which is closed when the pressure in the inner chamber of the secondary filter drops, and opened when the operation returns to normal operation.
3. The filtering device according to claim 1, further comprising a valve.
【請求項4】2次フィルタの内室内の圧力降下後、該フ
ィルタの洗浄前に、該フィルタの内,外室内に残存して
いる血漿を洗浄液と置換して返送ライン側に回収するた
めの手段を備えていることを特徴とする請求の範囲第1
〜3項のいずれか1つに記載の血漿濾過装置。
4. After the pressure drop in the inner chamber of the secondary filter, before the filter is washed, the plasma remaining in the outer and inner chambers of the filter is replaced with the washing liquid and collected on the return line side. Claim 1 characterized by comprising means
Item 4. The plasma filtration device according to any one of Items 3 to 3.
【請求項5】2次フィルタの洗浄後、通常運転に戻る前
に、2次フィルタの内室内の洗浄液を供給ライン側から
送られてくる血漿と置換して系外へ排出するための手段
を備えていることを特徴とする請求の範囲第4項記載の
血漿濾過装置。
5. After the secondary filter has been washed, before returning to normal operation, a means for replacing the washing liquid in the inner chamber of the secondary filter with plasma sent from the supply line side and discharging it to the outside of the system is provided. The plasma filtration device according to claim 4, further comprising:
【請求項6】2次フィルタへの処理前血漿の供給が中断
している間、該血漿をその供給ラインから返送ラインに
直接戻すためのバイパスラインを備えていることを特徴
とする請求の範囲第4項記載の血漿濾過装置。
6. The apparatus according to claim 1, further comprising a bypass line for directly returning the plasma from the supply line to the return line while the supply of the pre-treatment plasma to the secondary filter is interrupted. 5. The plasma filtration device according to claim 4.
JP4506572A 1991-03-26 1992-03-24 Plasma filtration method and apparatus therefor Expired - Lifetime JP2932101B2 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
JP3-61747 1991-03-26
CH2888/91-8 1991-09-30
CH288791 1991-09-30
CH288891 1991-09-30
CH2887/91-6 1991-09-30
CH1139/92-2 1992-04-08
PCT/EP1992/002131 WO1993007234A1 (en) 1991-09-30 1992-09-16 Halovinyl-derivatives

Publications (2)

Publication Number Publication Date
JPH06503362A JPH06503362A (en) 1994-04-14
JP2932101B2 true JP2932101B2 (en) 1999-08-09

Family

ID=47149001

Family Applications (1)

Application Number Title Priority Date Filing Date
JP4506572A Expired - Lifetime JP2932101B2 (en) 1991-03-26 1992-03-24 Plasma filtration method and apparatus therefor

Country Status (1)

Country Link
JP (1) JP2932101B2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW305872B (en) * 1995-06-08 1997-05-21 Chisso Corp
JP3780547B2 (en) * 1995-09-13 2006-05-31 大日本インキ化学工業株式会社 Bicyclohexane derivative
AU7227996A (en) * 1995-10-12 1997-04-30 Chisso Corporation Fluoroalkenyl derivatives and liquid crystal compositions
JP5531954B2 (en) * 2008-05-29 2014-06-25 Jnc株式会社 Liquid crystalline tetracyclic compound having fluorine atom, liquid crystal composition, and liquid crystal display device
JP2014019646A (en) * 2012-07-12 2014-02-03 Jnc Corp Liquid crystal compound having fluorovinyl group, liquid crystal composition and liquid crystal display element

Also Published As

Publication number Publication date
JPH06503362A (en) 1994-04-14

Similar Documents

Publication Publication Date Title
EP0531540B1 (en) Method and device for filtering plasma
US20080156729A1 (en) Automatic apparatus for blood dialysis and priming method using the apparatus
JPH05184885A (en) Method for cleaning meso-porous tubular membrane of ultrafiltration
WO1986003423A1 (en) Flow through filter with backflush clearing capability
CN112299510A (en) Water purifier, water purification system and control method thereof
DE3687453T2 (en) DEVICE FOR FILTRATING PLASMA FROM BLOOD.
JP2932101B2 (en) Plasma filtration method and apparatus therefor
WO1994016751A1 (en) Secondary filter cleaning method in blood plasma filtration method
JP3488535B2 (en) Chemical solution cleaning method for membrane in immersion type membrane filtration device and chemical solution cleaning device
JPS5911865A (en) Blood purifier
CN213802961U (en) Water purifier and water purification system thereof
JP2808682B2 (en) Membrane separation device
JPS6032897A (en) Dewaxing device
JPH11290060A (en) Cell separation filter suitable for recovering cell, cell separation system and separation of cell
JP2002263412A (en) Method for washing filter
RU2282489C2 (en) Cleaning of filter on base of hollow fibers at frontal mode of operation
JPH0116182B2 (en)
JP3255473B2 (en) Filtration concentration device and filtration concentration method
JP4414493B2 (en) Raw material processing method using filter
JPH026824A (en) Method and apparatus for filtration
JPS63127765A (en) Filter
JP2023075575A (en) body cavity fluid treatment system
JP2527987B2 (en) Solid / liquid separation device with filter cloth
JPH055511B2 (en)
JPH10180055A (en) Backwashing method of filter device

Legal Events

Date Code Title Description
R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313113

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

EXPY Cancellation because of completion of term